Keywords: Swedish Orphan Biovitrum, SOBI, Savient Pharma, Kineret, Co-promotion, USA, Rheumatoid arthritis, NOMID

SOBI links with Savient for co-promotion of Kineret in USA

Article | 19 February 2013

Print This

Swedish Orphan Biovitrum (STO: SOBI) says it has entered into an agreement with USA-based Savient Pharmaceuticals (Nasdaq: SVNT) for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in